Oral vitamin D3 decreases fracture risk in the elderly
- PMID: 12791218
Oral vitamin D3 decreases fracture risk in the elderly
Abstract
Vitamin D3 (or its physiologic equivalent, ergocalciferol), administered at a dose of 100,000 IU every 4 months for 5 years, is effective for primary prevention of fractures in the active elderly aged 65 to 85 years. This treatment regimen has no effect on cardiovascular, cancer, or all-cause mortality. Despite a seemingly large dose averaging 800 IU per day, this regimen is a safe, cheap (<$2 per year), and effective therapy for primary prevention of fractures.
Comment on
-
Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial.BMJ. 2003 Mar 1;326(7387):469. doi: 10.1136/bmj.326.7387.469. BMJ. 2003. PMID: 12609940 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources